Veracyte, Inc. (Nasdaq: VCYT) announced today that Marc Stapley, chief executive officer, and Rebecca Chambers, chief financial officer, will present at the 42nd annual J.P. Morgan Healthcare Conference on Monday, January 8, 2024, at 1:30 p.m. Pacific Time.

A live audio webcast of the company’s presentation will be available by visiting Veracyte’s website at http://investor.veracyte.com/events-presentations. A replay of the webcast will be available for 30 days following the conclusion of the live broadcast.

About Veracyte

Veracyte (Nasdaq: VCYT) is a global diagnostics company whose vision is to transform cancer care for patients all over the world. We empower clinicians with the high-value insights they need to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. Our high-performing tests enable clinicians to make more confident diagnostic, prognostic, and treatment decisions for some of the most challenging diseases such as thyroid, prostate, breast, bladder and lung cancers, as well as interstitial lung diseases. We help patients avoid unnecessary procedures and speed time to diagnosis and appropriate treatment. In addition to making our tests available in the U.S. through our central laboratories, we also aim to deliver our tests to patients worldwide through a distributed model to laboratories that can perform them locally. For more information, please visit www.veracyte.com and follow the company on Twitter (@veracyte).

Investors: Shayla Gorman Sr. Director, Investor Relations investors@veracyte.com 619-393-1545

Media: Tracy Morris Vice President of Global Corporate Communications tracy.morris@veracyte.com 650-380-4413

Veracyte (NASDAQ:VCYT)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024 Veracyte 차트를 더 보려면 여기를 클릭.
Veracyte (NASDAQ:VCYT)
과거 데이터 주식 차트
부터 6월(6) 2023 으로 6월(6) 2024 Veracyte 차트를 더 보려면 여기를 클릭.